The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at strengthening tuberculosis (TB) prevention, diagnosis, and treatment in Southeast Asia, with a focus on reducing TB burden and mortality in high-burden countries. The initiative seeks to implement innovative approaches to enhance early TB diagnosis, advance TB prevention interventions, and improve treatment outcomes for individuals affected by TB, including those with drug-resistant strains. This funding opportunity, with an estimated total of $10 million for the first fiscal year, is open to unrestricted applicants, and interested parties can reach out to the CDC at pepfarfoas@cdc.gov for further information. Applications must be submitted electronically by 11:59 PM ET on February 17, 2026, with awards expected to be announced by September 30, 2026.